MariMed (OTCMKTS:MRMD) Releases Earnings Results, Hits Expectations

MariMed (OTCMKTS:MRMD) released its quarterly earnings results on Wednesday. The company reported ($0.01) EPS for the quarter, hitting analysts’ consensus estimates of ($0.01), Zacks reports. MariMed had a negative return on equity of 5.00% and a negative net margin of 7.82%.

MariMed Stock Down 8.0%

MRMD stock traded down $0.01 during mid-day trading on Wednesday, hitting $0.06. 460,212 shares of the company were exchanged, compared to its average volume of 508,118. The company has a debt-to-equity ratio of 1.67, a quick ratio of 0.34 and a current ratio of 0.95. The firm has a market cap of $25.71 million, a P/E ratio of -2.14 and a beta of 1.33. The firm’s 50 day simple moving average is $0.07 and its 200 day simple moving average is $0.08. MariMed has a 1-year low of $0.06 and a 1-year high of $0.23.

About MariMed

MariMed Inc is a multi‐state cannabis company focused on the development, ownership and operation of regulated facilities for the medical and adult‐use cannabis markets. Headquartered in New Bedford, Massachusetts, the company cultivates, processes and dispenses cannabis through an integrated business model that encompasses cultivation, formulation, manufacturing and retail operations. MariMed operates under its own licensed brands and through strategic partnerships to expand its presence across the United States.

The company’s product portfolio includes branded flower, pre‐rolls, vaporizer cartridges, tinctures, edibles and topicals designed to meet a range of consumer and patient needs.